GNW:NYE-Genworth Financial Inc (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 6.74

Change

-0.11 (-1.61)%

Market Cap

N/A

Volume

2.10M

Analyst Target

USD 3.50
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
AFL Aflac Incorporated

-0.92 (-0.84%)

USD 61.10B
MET-PA MetLife Inc Preferred Stock Se..

-0.03 (-0.12%)

USD 48.23B
MET-PE MetLife Inc Preferred Stock Se..

+0.05 (+0.20%)

USD 44.41B
PRU Prudential Financial Inc

-0.98 (-0.81%)

USD 43.48B
PUK Prudential Public Limited Comp..

+0.42 (+2.44%)

USD 23.20B
PRI Primerica Inc

-1.44 (-0.54%)

USD 8.74B
JXN Jackson Financial Inc

-0.92 (-1.02%)

USD 6.55B
FG F&G Annuities & Life Inc.

-0.10 (-0.23%)

USD 5.34B
ANG-PB American National Group Inc

-0.01 (-0.04%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

+0.07 (+0.30%)

N/A

ETFs Containing GNW

INAU 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.90% 22% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.90% 22% F 21% F
Trailing 12 Months  
Capital Gain 16.01% 39% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.01% 33% F 42% F
Trailing 5 Years  
Capital Gain 51.12% 53% F 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.12% 47% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 17.87% 67% D+ 81% B-
Dividend Return 17.87% 56% F 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 22.16% 72% C 47% F
Risk Adjusted Return 80.65% 89% A- 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector